Interactive modulation of renal myogenic autoregulation by nitric oxide and endothelin acting through ET-B receptors

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 1, 2007, Pages

  Shi, Ying ^a,b,d   Lau, Catherine ^b,c   Cupples, William A ^b,c  

^a Gina Cody School of Engineering and Computer Science   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

BQ 788; Dynamics; L NAME; Myogenic mechanism

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ARTICLE; AUTOREGULATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; KIDNEY BLOOD VESSEL; KIDNEY PERFUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; RENAL ARTERY; TIME SERIES ANALYSIS; VASOCONSTRICTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DATA INTERPRETATION, STATISTICAL; ENDOTHELINS; ENZYME INHIBITORS; HOMEOSTASIS; KIDNEY; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN B; RENAL CIRCULATION; VASCULAR RESISTANCE;

EID: 33846144425     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00440.2006     Document Type: Article

References (42)

1. Banting JD, Friberg P, Adams MA. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J Hypertens 14: 975-981, 1996.
2. Baumann JE, Persson PB, Ehmke H, Nafz B, Kirchheim HR. Role of endothelium-derived relaxing factor in renal autoregulation in conscious dogs. Am J Physiol Renal Fluid Electrolyte Physiol 263: F208-F213, 1992.
3. Beierwaltes WH, Sigmon DH, Carretero OA. Endothelium modulates renal blood flow but not autoregulation. Am J Physiol Renal Fluid Electrolyte Physiol 262: F943-F949, 1992.
4. Berthold H, Munter K, Just A, Kirchheim HR, Ehmke H. Contribution of endothelin to renal vascular tone and autoregulation in the conscious dog. Am J Physiol Renal Physiol 276: F417-F424, 1999.
5. Bouriquet N, Casellas D. Interaction between cGMP-dependent dilators and autoregulation in rat preglomerular vasculature. Am J Physiol Renal Fluid Electrolyte Physiol 268: F338-F346, 1995.
6. Cupples WA, Sakai T, Marsh DJ. Angiotensin II and prostaglandins in control of vasa recta blood flow. Am J Physiol Renal Fluid Electrolyte Physiol 254: F417-F424, 1988.
7. Cupples WA, Novak P, Novak V, Salevsky FC. Spontaneous blood pressure fluctuations and renal blood flow dynamics. Am J Physiol Renal Fluid Electrolyte Physiol 270: F82-F89, 1996.
8. Cupples WA, Ajikobi DO, Wang X. Kidney-specific responses of myogenic autoregulation to inhibition of nitric oxide synthase. In: The IMA Volumes in Mathematics and Its Applications, Vol 129: Membrane Transport and Renal Physiology, edited by Layton HE and Weinstein AM. New York: Springer, 2002, p. 293-310.
9. Doherty AM, Cody WL, He JX, Depue PL, Cheng XM, Welch KM, Flynn MA, Reynolds EE, Ladouceur DM, Davis LS, Keiser JA, Haleen SJ. In vitro and in vivo studies with a series of hexapeptide endothelin antagonists. J Cardiovasc Pharmacol 22: S98-S102, 1993.
10. Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199: 1461-1465, 1994.
11. Hayashi K, Suzuki H, Saruta T. Nitric oxide modulates but does not impair myogenic vasoconstriction of the afferent arteriole in spontaneously hypertensive rats: studies in the isolated perfused hydronephrotic kidney. Hypertension 25: 1212-1219, 1995.
12. Hoffend J, Cavarape A, Endlich K, Steinhausen M. Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation. Am J Physiol Renal Fluid Electrolyte Physiol 265: F285-F292, 1993.
13. Ichihara A, Navar LG. Neuronal NOS contributes to biphasic autoregulatory response during enhanced TGF activity. Am J Physiol Renal Physiol 277: F113-F120, 1999.
14. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Fukami T, Ishikawa K, Nishikibe M, Yano M. Biological profiles of highly potent endothelin antagonists selective for the ETA receptor. Life Sci 50: 247-255, 1992.
15. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Hishikibe M, Yano M. Biochemical and pharmacological profile of a potent and selective endothelin Breceptor antagonist, BQ-788. Proc Natl Acad Sci USA 91: 4892-4896, 1994.
16. Just A, Arendshorst WJ. Nitric oxide blunts myogenic autoregulation in rat renal but not skeletal muscle circulation via tubuloglomerular feedback. J Physiol 569: 959-974, 2005.
17. Just A, Ehmke H, Wittmann U, Kirchheim HR. Tonic and phasic influences of nitric oxide on renal blood flow autoregulation in conscious dogs. Am J Physiol Renal Physiol 276: F442-F449, 1999.
18. A receptors. Am J Physiol Renal Physiol 286: F660-F668, 2004.
19. Just A, Olson AJ, Falck JR, Arendshorst WJ. NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat. Am J Physiol Regul Integr Comp Physiol 288: R1168-R1177, 2005.
20. Karaki H, Sudjarwo SA, Hori M. Novel antagonist of endothelin ETB1 and ETB2 receptors, BQ-788: effects on blood vessel and small intestine. Biochem Biophys Res Commun 205: 168-173, 1994.
21. Kirton CA, Loutzenhiser R. Alterations in basal protein kinase C activity modulate renal afferent arteriolar myogenic reactivity. Am J Physiol Heart Circ Physiol 275: H467-H475, 1998.
22. Kramer HJ, Horacek V, Backer A, Vaneckova I, Heller J. Relative roles of nitric oxide, prostanoids and angiotensin II in the regulation of canine glomerular hemodynamics. A micropuncture study. Kidney Blood Press Res 27: 10-17, 2004.
23. 2+ channel activity on renal hemodynamics during acute attenuation of NO synthesis in the rat. Am J Physiol Renal Physiol 278: F561-F569, 2000.
24. Kramp R, Fourmanoir P, Caron N. Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat. Am J Physiol Renal Physiol 281: F1132-F1140, 2001.
25. Lautt WW, Plaa GL. Hemodynamic effects of CCl4 in the intact liver of the cat. Can J Physiol Pharmacol 52: 727-735, 1974.
26. Majid DSA, Williams A, Kadowitz PJ, Navar LG. Renal responses to intra-arterial administration of nitric oxide donor in dogs. Hypertension 22: 535-541, 1993.
27. Milhorn TH. The Application of Control Theory to Physiological Systems. Philadelphia, PA: Saunders, 1966, p. 170-174.
28. Mino N, Kobayashi M, Nakajima A, Amano H, Shimamoto K, Ishikawa K, Watanabe K, Nishikibe M, Yano M, Ikemoto F. Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur J Pharmacol 221: 77-83, 1992.
29. Parekh N. A novel method for infusing drugs continuously into the renal artery of rats. Am J Physiol Renal Fluid Electrolyte Physiol 268: F967-F971, 1995.
30. Qiu C, Baylis C. Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibition. Kidney Int 55: 2390-2396, 1999.
31. Racasan S, Joles JA, Boer P, Koomans HA, Braam B. NO dependency of RBF and autoregulation in the spontaneously hypertensive rat. Am J Physiol Renal Physiol 285: F105-F112, 2003.
32. Shi Y, Wang X, Chon KH, Cupples WA. Tubuloglomerular feedback-dependent modulation of renal myogenic autoregulation by nitric oxide. Am J Physiol Regul Integr Comp Physiol 290: R982-R991, 2006.
33. Schmidt A, Bayerle-Eder M, Pleiner H, Zeisner C, Wolzt M, Mayer G, Schmetterer L. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men. Nitric Oxide: Biology and Chemistry 5: 370-376, 2006.
34. Takabatake T, Ise T, Ohta K, Kobayashi K. Effects of endothelin on renal hemodynamics and tubuloglomerular feedback. Am J Physiol Renal Fluid Electrolyte Physiol 263: F103-F108, 1992.
35. Transonic Systems. Accoustical couplants for acute measurements [On-line]. http://www.transonic.com/Research_Home/Technical_Notes/ TN9AcouticalCouplants. [15 Sept. 2006].
36. Trottier G, Triggle CR, O'Neill SK, Loutzenhiser R. Cyclic GMP-dependent and cyclic GMP-independent actions of nitric oxide on the renal afferent arteriole. Br J Pharmacol 125: 563-569, 1998.
37. B receptor in endothelial cells. Receptor coupling to nitric oxide synthase. J Biol Chem 269: 21778-21785, 1994.
38. Turkstra E, Braam B, Koomans HA. Impaired renal blood flow autoregulation in two-kidney, one-clip hypertensive rats is caused by enhanced activity of nitric oxide. J Am Soc Nephrol 11: 847-855, 2000.
39. Victorino GP, Wisner DH, Tucker VL. Basal release of endothelin-1 and the influence of the ETB receptor in single vessel hydraulic permeability. J Trauma 49: 314-319, 2000.
40. Wang X, Cupples WA. Interaction between nitric oxide and renal myogenic autoregulation in normotensive and hypertensive rats. Can J Physiol Pharmacol 79: 238-245, 2001.
41. Wang X, Salevsky FC, Cupples WA. Nitric oxide, atrial natriuretic factor, and dynamic renal autoregulation. Can J Physiol Pharmacol 77: 777-786, 1999.
42. Wang X, Ajikobi DO, Salevsky FC, Cupples WA. Impaired myogenic autoregulation in kidneys of Brown Norway rats. Am J Physiol Renal Physiol 278: F962-F969, 2000.